Insight Molecular Diagnostics (IMDX) Shares Outstanding (2020 - 2025)
Historic Shares Outstanding for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $28.6 million.
- Insight Molecular Diagnostics' Shares Outstanding rose 11403.47% to $28.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.6 million, marking a year-over-year increase of 11403.47%. This contributed to the annual value of $17.5 million for FY2024, which is 11126.98% up from last year.
- As of Q3 2025, Insight Molecular Diagnostics' Shares Outstanding stood at $28.6 million, which was up 11403.47% from $28.6 million recorded in Q2 2025.
- Insight Molecular Diagnostics' Shares Outstanding's 5-year high stood at $92.2 million during Q3 2021, with a 5-year trough of $4.6 million in Q4 2021.
- For the 5-year period, Insight Molecular Diagnostics' Shares Outstanding averaged around $24.6 million, with its median value being $8.3 million (2024).
- Per our database at Business Quant, Insight Molecular Diagnostics' Shares Outstanding skyrocketed by 13693588.05% in 2021 and then plummeted by 9481.3% in 2022.
- Quarter analysis of 5 years shows Insight Molecular Diagnostics' Shares Outstanding stood at $4.6 million in 2021, then grew by 28.62% to $5.9 million in 2022, then skyrocketed by 39.26% to $8.3 million in 2023, then surged by 111.27% to $17.5 million in 2024, then surged by 64.01% to $28.6 million in 2025.
- Its Shares Outstanding was $28.6 million in Q3 2025, compared to $28.6 million in Q2 2025 and $28.6 million in Q1 2025.